NYSE · CIK 0000010456
BAX BAXTER INTERNATIONAL INC
Insider trading from SEC Form 4. Last filing 39 d ago. Close $24.35 on Oct 9, 2026, +54% from the 52-week low and -14% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
23
with a Form 4 at this company
Price and insider trades, last year
BAXOct 9, 2026 · close 24.35
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at BAXTER INTERNATIONAL INC, scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Congressional trades
7 trades in BAX disclosed by members of Congress under the STOCK Act. All congressional trades.
- Lisa C. McClainHouse · R-MI · last Nov 21, 20253 bought
3 sold - Robert P. Bresnahan, Jr.House · R-PA · last Jun 9, 20251 bought
0 sold
| Member | Trade | Asset | Reported range | Trade / filing date | Source |
|---|---|---|---|---|---|
Lisa C. McClain House · R-MI | Purchase | BAX Baxter International Inc. Common Stock | $1,001 to $15k | Oct 30, 2025 / Nov 21, 2025 22 days after the trade | Clerk |
Lisa C. McClain House · R-MI | Sale | BAX Baxter International Inc. Common Stock | $1,001 to $15k | Oct 30, 2025 / Nov 21, 2025 22 days after the trade | Clerk |
Lisa C. McClain House · R-MI | Sale | BAX Baxter International Inc. Common Stock | $1,001 to $15k | Oct 31, 2025 / Nov 21, 2025 21 days after the trade | Clerk |
Lisa C. McClain House · R-MI | Purchase | BAX Baxter International Inc. Common Stock | $1,001 to $15k | Sep 25, 2025 / Oct 22, 2025 27 days after the trade | Clerk |
Lisa C. McClain House · R-MI | Sale | BAX Baxter International Inc. Common Stock | $1,001 to $15k | Aug 4, 2025 / Sep 12, 2025 39 days after the trade | Clerk |
Lisa C. McClain House · R-MI | Purchase | BAX Baxter International Inc. Common Stock | $1,001 to $15k | Jul 22, 2025 / Aug 13, 2025 22 days after the trade | Clerk |
Robert P. Bresnahan, Jr. House · R-PA | Purchase | BAX Baxter International Inc. Common Stock | $1,001 to $15k | May 15, 2025 / Jun 9, 2025 25 days after the trade | Clerk |
Transactions
The last 55 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Andrew P. Hider President and CEO | FTax withholding Common Stock, $1 par value | -54,276 | $25.70 | $1.4M | 518,447 | 39 d ago |
| Sep 1, 2026 | James Teaff President, CCS | FTax withholding Common Stock, $1 par value | -750 | $25.48 | $19k | 30,370 | 39 d ago |
| Sep 2, 2026 | Julie Foster President, Front Line Care | FTax withholding Common Stock, $1 par value | -2,098 | $25.70 | $54k | 29,164 | 39 d ago |
| Sep 2, 2025 | James W Borzi EVP,Chief Supply Chain Officer | FTax withholding Common Stock, $1 par value | -1,848 | $24.17 | $45k | 71,948 | Sep 4, 2025 |
| Sep 2, 2025 | Joel T. Grade EVP and CFO | AGrant or award Common Stock, $1 par value | +102,712 | $0.00 | $0 | 222,560 | Sep 4, 2025 |
| Sep 2, 2025 | Andrew P. Hider President and CEO | AGrant or award Common Stock, $1 par value | +236,237 | $0.00 | $0 | 236,237 | Sep 4, 2025 |
| Sep 2, 2025 | Alok Sonig EVP,Group President,Pharma | FTax withholding Common Stock, $1 par value | -3,191 | $24.17 | $77k | 128,219 | Sep 4, 2025 |
| Sep 2, 2025 | Andrew P. Hider President and CEO | AGrant or award Common Stock, $1 par value | +131,813 | $0.00 | $0 | 368,050 | Sep 4, 2025 |
| Sep 2, 2025 | Andrew P. Hider President and CEO | AGrant or award Stock Option (Right to Buy)derivative | +465,651 | $0.00 | $0 | 465,651 | Sep 4, 2025 |
| Aug 19, 2025 | David Brent Shafer Interim CEO and Chair | FTax withholding Common Stock, $1 par value | -31,337 | $24.33 | $762k | 59,446 | Aug 21, 2025 |
| Jun 2, 2025 | David S. Rosenbloom EVP and General Counsel | FTax withholding Common Stock, $1 par value | -16,548 | $29.55 | $489k | 106,327 | Jun 4, 2025 |
| May 6, 2025 | Cathy R Smith director | AGrant or award Common Stock, $1 par value | +7,183 | $0.00 | $0 | 30,345 | May 8, 2025 |
| May 6, 2025 | Jeffrey A Craig director | AGrant or award Common Stock, $1 par value | +7,183 | $0.00 | $0 | 10,672 | May 8, 2025 |
| May 6, 2025 | David S. Wilkes director | AGrant or award Common Stock, $1 par value | +7,183 | $0.00 | $0 | 23,906 | May 8, 2025 |
| May 6, 2025 | Amy McBride Wendell director | AGrant or award Common Stock, $1 par value | +7,183 | $0.00 | $0 | 31,222 | May 8, 2025 |
| May 6, 2025 | Stephen H Rusckowski director | AGrant or award Common Stock, $1 par value | +7,183 | $0.00 | $0 | 16,499 | May 8, 2025 |
| May 6, 2025 | Stephen N. Oesterle director | AGrant or award Common Stock, $1 par value | +7,183 | $0.00 | $0 | 35,847 | May 8, 2025 |
| May 6, 2025 | Patricia Morrison director | AGrant or award Common Stock, $1 par value | +7,183 | $0.00 | $0 | 29,137 | May 8, 2025 |
| May 6, 2025 | William A. Ampofo II director | AGrant or award Common Stock, $1 par value | +7,183 | $0.00 | $0 | 17,299 | May 8, 2025 |
| May 6, 2025 | Nancy M Schlichting director | AGrant or award Common Stock, $1 par value | +7,183 | $0.00 | $0 | 21,850 | May 8, 2025 |
| Mar 6, 2025 | Joel T. Grade EVP and CFO | FTax withholding Common Stock, $1 par value | -4,306 | $35.44 | $153k | 88,896 | Mar 10, 2025 |
| Mar 6, 2025 | Reazur Rasul EVP,Group Pres,Healthcare | FTax withholding Common Stock, $1 par value | -9,341 | $35.44 | $331k | 98,394 | Mar 10, 2025 |
| Mar 6, 2025 | Jeanne K Mason EVP, Chief HR Officer | FTax withholding Common Stock, $1 par value | -4,375 | $35.44 | $155k | 183,963 | Mar 10, 2025 |
| Mar 6, 2025 | David S. Rosenbloom EVP and General Counsel | FTax withholding Common Stock, $1 par value | -4,922 | $35.44 | $174k | 104,780 | Mar 10, 2025 |
| Mar 6, 2025 | Heather Knight EVP, Chief Operating Officer | FTax withholding Common Stock, $1 par value | -13,634 | $35.44 | $483k | 141,688 | Mar 10, 2025 |
| Mar 6, 2025 | Alok Sonig EVP,Group President,Pharma | FTax withholding Common Stock, $1 par value | -10,839 | $35.44 | $384k | 100,332 | Mar 10, 2025 |
| Mar 6, 2025 | Anita A Zielinski SVP, CAO and Controller | AGrant or award Common Stock, $1 par value | +17,123 | $0.00 | $0 | 17,123 | Mar 10, 2025 |
| Mar 6, 2025 | James W Borzi EVP,Chief Supply Chain Officer | FTax withholding Common Stock, $1 par value | -3,262 | $35.44 | $116k | 63,145 | Mar 10, 2025 |
| Mar 6, 2025 | David S. Rosenbloom EVP and General Counsel | AGrant or award Common Stock, $1 par value | +17,658 | $0.00 | $0 | 122,438 | Mar 10, 2025 |
| Mar 6, 2025 | Alok Sonig EVP,Group President,Pharma | AGrant or award Common Stock, $1 par value | +29,966 | $0.00 | $0 | 130,298 | Mar 10, 2025 |
| Mar 6, 2025 | Reazur Rasul EVP,Group Pres,Healthcare | AGrant or award Common Stock, $1 par value | +26,220 | $0.00 | $0 | 124,614 | Mar 10, 2025 |
| Mar 6, 2025 | Heather Knight EVP, Chief Operating Officer | AGrant or award Common Stock, $1 par value | +35,674 | $0.00 | $0 | 177,362 | Mar 10, 2025 |
| Mar 6, 2025 | Jeanne K Mason EVP, Chief HR Officer | AGrant or award Common Stock, $1 par value | +15,696 | $0.00 | $0 | 199,659 | Mar 10, 2025 |
| Mar 6, 2025 | Joel T. Grade EVP and CFO | AGrant or award Common Stock, $1 par value | +29,538 | $0.00 | $0 | 118,434 | Mar 10, 2025 |
| Mar 6, 2025 | James W Borzi EVP,Chief Supply Chain Officer | AGrant or award Common Stock, $1 par value | +9,989 | $0.00 | $0 | 73,134 | Mar 10, 2025 |
| Mar 6, 2025 | Reazur Rasul EVP,Group Pres,Healthcare | AGrant or award Stock Option (Right to Buy)derivative | +87,417 | $0.00 | $0 | 87,417 | Mar 10, 2025 |
| Mar 6, 2025 | Heather Knight EVP, Chief Operating Officer | AGrant or award Stock Option (Right to Buy)derivative | +118,934 | $0.00 | $0 | 118,934 | Mar 10, 2025 |
| Mar 6, 2025 | Joel T. Grade EVP and CFO | AGrant or award Stock Option (Right to Buy)derivative | +98,478 | $0.00 | $0 | 98,478 | Mar 10, 2025 |
| Mar 6, 2025 | David S. Rosenbloom EVP and General Counsel | AGrant or award Stock Option (Right to Buy)derivative | +58,873 | $0.00 | $0 | 58,873 | Mar 10, 2025 |
| Mar 6, 2025 | James W Borzi EVP,Chief Supply Chain Officer | AGrant or award Stock Option (Right to Buy)derivative | +33,302 | $0.00 | $0 | 33,302 | Mar 10, 2025 |
| Mar 6, 2025 | Alok Sonig EVP,Group President,Pharma | AGrant or award Stock Option (Right to Buy)derivative | +99,905 | $0.00 | $0 | 99,905 | Mar 10, 2025 |
| Mar 6, 2025 | Jeanne K Mason EVP, Chief HR Officer | AGrant or award Stock Option (Right to Buy)derivative | +52,331 | $0.00 | $0 | 52,331 | Mar 10, 2025 |
| Mar 3, 2025 | Heather Knight EVP, Chief Operating Officer | FTax withholding Common Stock, $1 par value | -3,344 | $34.86 | $117k | 155,323 | Mar 5, 2025 |
| Mar 3, 2025 | Alok Sonig EVP,Group President,Pharma | FTax withholding Common Stock, $1 par value | -1,936 | $34.86 | $67k | 111,171 | Mar 5, 2025 |
| Mar 3, 2025 | David S. Rosenbloom EVP and General Counsel | FTax withholding Common Stock, $1 par value | -1,312 | $34.86 | $46k | 109,703 | Mar 5, 2025 |
| Mar 3, 2025 | Reazur Rasul EVP,Group Pres,Healthcare | FTax withholding Common Stock, $1 par value | -1,987 | $34.86 | $69k | 107,735 | Mar 5, 2025 |
| Mar 3, 2025 | Jeanne K Mason EVP, Chief HR Officer | FTax withholding Common Stock, $1 par value | -1,479 | $34.86 | $52k | 188,339 | Mar 5, 2025 |
| Mar 3, 2025 | James W Borzi EVP,Chief Suppy Chain Officer | FTax withholding Common Stock, $1 par value | -1,339 | $34.86 | $47k | 66,407 | Mar 5, 2025 |
| Feb 5, 2025 | David Brent Shafer Interim CEO and Chair | AGrant or award Common Stock, $1 par value | +76,289 | $0.00 | $0 | 89,841 | Feb 6, 2025 |
| Jan 31, 2025 | Christopher A. Toth EVP, Group Pres, Kidney Care | FTax withholding Common Stock, $1 par value | -25,372 | $32.56 | $826k | 105,186 | Feb 4, 2025 |
| Dec 31, 2024 | Christopher A. Toth EVP,Group Pres, Kidney Care | FTax withholding Common Stock, $1 par value | -32,610 | $29.16 | $951k | 183,876 | Jan 3, 2025 |
| Dec 13, 2024 | Jose E Almeida Chairman, CEO, President | FTax withholding Common Stock, $1 par value | -5,966 | $30.32 | $181k | 243,589 | Dec 17, 2024 |
| Dec 2, 2024 | Joel T. Grade EVP and CFO | FTax withholding Common Stock, $1 par value | -6,612 | $33.55 | $222k | 92,457 | Dec 4, 2024 |
| Dec 2, 2024 | Heather Knight EVP, Group Pres, Med Products | FTax withholding Common Stock, $1 par value | -6,041 | $33.55 | $203k | 157,674 | Dec 4, 2024 |
| Dec 2, 2024 | Reazur Rasul EVP,Group Pres,Healthcare | FTax withholding Common Stock, $1 par value | -2,032 | $33.55 | $68k | 109,116 | Dec 4, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Jose E AlmeidaChairman, CEO, President
- William A. Ampofo IIdirector
- James W BorziEVP,Chief Supply Chain Officer
- Jeffrey A Craigdirector
- Julie FosterPresident, Front Line Care
- Joel T. GradeEVP and CFO
- Andrew P. HiderPresident and CEO
- Heather KnightEVP, Chief Operating Officer
- Patricia Morrisondirector
- Jeanne K MasonEVP, Chief HR Officer
- Stephen N. Oesterledirector
- Stephen H Rusckowskidirector
- Reazur RasulEVP,Group Pres,Healthcare
- David S. RosenbloomEVP and General Counsel
- Nancy M Schlichtingdirector
- David Brent ShaferInterim CEO and Chair
- Cathy R Smithcfo, officer, director
- Alok SonigEVP,Group President,Pharma
- James TeaffPresident, CCS
- Christopher A. TothEVP, Group Pres, Kidney Care
- Amy McBride Wendelldirector
- David S. Wilkesdirector
- Anita A ZielinskiSVP, CAO and Controller
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.